Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva. Abstract. PASQUALOTTO, Alessandro Comarú; MATTOS, Alice J.Z. de and ROCHA, Marineide Melo. Leucoencefalopatia multifocal progressiva confirmada por. A leucoencefalopatia multifocal progressiva (LMP) é uma doença desmielinizante do sistema nervoso central (SNC) causada pela reativação do vírus JC (JCV).

Author: Tauran Faulmaran
Country: Moldova, Republic of
Language: English (Spanish)
Genre: History
Published (Last): 16 June 2006
Pages: 174
PDF File Size: 5.36 Mb
ePub File Size: 14.10 Mb
ISBN: 380-2-75846-603-1
Downloads: 39346
Price: Free* [*Free Regsitration Required]
Uploader: Doshakar

If untreated, PML is usually fatal within one year, often within 2 to 6 months Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan.

Migraine Familial hemiplegic Cluster Tension. It is caused by the reactivation of the JC virus genus: Progressive multifocal leukoencephalopathy a review of the neuroimaging features and differential diagnosis. Journal List Dement Neuropsychol v.

The JC virus is harmless except in cases of weakened immune systems.

Atwood, Walter J, ed. BK virus MuV Mumps.

Progressive multifocal leukoencephalopathy – Wikipedia

Most of the reported patients who developed IRIS received high-dose glucocorticoids dexamethasone or methylprednisolone followed by a slow tapering in order to lessen the immune reconstitution and avoid additional damage Braz J Iinfect Dis ; There are reports of JCV isolation in the CSF of immunocompetent and immunosuppressed patients with a meningeal syndrome and no focal symptoms PML can still occur in people on immunosuppressive therapy, such as efalizumab, [7] belatacept, [8] and various transplant drugs, which are meant to weaken the immune system.

Improved survival of HIVinfected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. In a study with a cohort of 98 PML patients from Spain, the use of antiretroviral regimens containing protease inhibitors were associated with reduction in mortality The benefit is modest at best, but it can be considered both in patients with and without HIV infection.


However, some authors believe that the impact of HAART was less evident in PML incidence compared to other central nervous system opportunistic infections 7.

Unusual viral infections progressive multifocal leukoencephalopathy and cytomegalovirus disease after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab.

Drugs such as cidofovir, cytarabine, topotecan and mefloquine were evaluated in several trials but results were disappointing and associated with serious adverse effects 1 2. There are no specific antivirals drugs against JCV. In patients on immunosuppression, this means stopping the drugs or using plasma exchange to accelerate the removal of the biologic agent that put the person at risk for PML.

Progressive multifocal leukoencephalopathy in patients with HIV infection. You can also scroll through stacks with your mouse wheel or the keyboard arrow keys.

Thereafter, the virus remains latent in the kidney, bone marrow and lymphoid organs, lecuoencefalopatia, in a setting of cellular immunosuppression, the virus reactivates, spreads to leucoencefalopattia central nervous system CNSleading to infection of oligodendrocytes and demyelination 1. However, the progrezsiva use of HIV antiretroviral drugs and new selective immunomodulatory and immunosuppressive medications, such as Rituximab and Natalizumab, had recently modified the epidemiology, clinical presentation and prognosis of PML 3.

JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. Two case reports of using interleukin-2 successfully have been published. National Institute of Neurological Disorders and Stroke. Despite the support therapy, the patient evolved with clinical and radiological deterioration Figure 3.

Mirtazapine, an antidepressant that acts inhibiting this receptor has been used in treatment of PML. PML is a demyelinating diseasein which the myelin sheath covering the axons of nerve cells is gradually destroyed, impairing the transmission of nerve impulses. This is an Open Access article distributed under the terms of the Creative Lleucoencefalopatia Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


It refers to a coalescent bilateral parieto-occipital Leucoencrfalopatia and FLAIR hyperintense lesion with rpogressiva of the splenium of the corpus callosum reminiscent of a barbell see case.

Progressive multifocal leukoencephalopathy

Clinically, the development of PML in multiple sclerosis patients poses an additional difficulty in the diagnosis, since PML onset is frequently mistaken with MS exacerbation, stroke or other neurological condition From the to ‘s, PML was observed mostly in patients being treated with corticosteroids and other immunosuppressive drugs, as well as individuals with hematological malignancies.

Clin Infect Dis ; National Institutes of Health. November Learn how and when to remove this template message. JC virus meningitis in a patient with systemic lupus erythematosus.

They can be variable in size and may coalesce. Other findings include infected oligodendrocytes with enlarged amphophilic nuclei located at the periphery of the lesions, macrophages containing phagocytosed cellular debris and myelin, and reactive gliosis with enlarged astrocytes Cidofovir was studied as possible treatment for PML [15] and has been used on a case-by-case basis, working in some, but not others.

This is in contradistinction to more symmetrical hypoattenuation seen in HIV encephalopathy. There may be involvement of deep gray structures, by affection of myelin fibers that pass through basal ganglia.

Author: admin